News
13 March 2024
VIVEbiotech contributes to a roundtable article in Pharma´s Almanac
VIVEbiotech has contributed to a roundtable article in Pharma's Almanac discussing strategies being employed to accelerate product development and commercialization without compromising quality.
Read more6 March 2024
VIVEbiotech receives the EmakumeEkinn award for promoting innovation and female talent
On the occasion of the celebration of International Women's Day, the Sociedad Fomento San Sebastián has made today a recognition to women who contribute...
Read more4 March 2024
Spanish researchers to design proteins using AI to make advanced therapies more efficient
The Ministry of Science, Innovation and Universities in collaboration with the Center for Technological Development and Innovation (CDTI) have selected it as one of the 40...
Read more20 February 2024
Scrip Citeline Commercial reports VIVEbiotech’s predictions for 2024
At the end of 2023, Scrip Citeline Commercial gave us the opportunity to provide predictions for the year ahead.
Read more14 February 2024
VIVEbiotech forecasts significant growth in lentiviral vectors and CAR-T therapies for 2024
Pharma Manufacturing asked Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, about her predictions on therapeutic advances for 2024.
Read more13 February 2024
VIVEbiotech presents at a Gyrolab Technology Seminar
Bárbara Rodríguez-Urretavizcaya, Analytical Development Scientist at VIVEbiotech, will be presenting today at a Gyrolab Technology Seminar.
Read more9 February 2024
VIVEbiotech participates in an article in Endpoints News about the challenges facing lentiviral vector production
VIVEbiotech participates in an article in Endpoints News about the challenges facing lentiviral vector production.
Read more23 January 2024
Article resulting from a webinar in collaboration with Xpress Biologics, Polyplus, Sartorius
On November 28th VIVEbiotech participated in a webinar invited by Xpress Biologics, Polyplus, Sartorius.
Read more23 January 2024
VIVEbiotech featured in an article in the Winter print issue of Drug Discovery World
Towards the end of last year, Natalia Elizalde, Chief Business Development Officer at VIVEbiotech, was asked about her predictions for 2024 by the Drug Discovery World.
Read more22 January 2024
Successful participation of VIVEbiotech at the Advanced Therapies Week
VIVEbiotech has successfully participated in the Advanced Therapies Week conference in Miami.
Read moreDestacadas
4 December 2024
25 October 2024
8 October 2024
18 September 2024
11 September 2024
9 September 2024
28 August 2024